about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorInvolvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosateCorticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanismNeuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and WithdrawalThe central amygdala as an integrative hub for anxiety and alcohol use disordersProopiomelanocortin (POMC) expression and conditioned place aversion during protracted withdrawal from chronic intermittent escalating-dose heroin in POMC-EGFP promoter transgenic mice.Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward.Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens.Central urocortin 3 administration decreases limited-access ethanol intake in nondependent miceOpioid modulators for alcohol dependence.Ontogeny of ethanol intake in alcohol preferring (P) and alcohol nonpreferring (NP) rats.Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF.Binge alcohol drinking elicits persistent negative affect in mice.Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptidesCorticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors.Disentangling the complex association between childhood sexual abuse and alcohol-related problems: a review of methodological issues and approaches.Associations Between Body Weight Status and Substance Use Among African American Women in Baltimore, Maryland: The CHAT Study.Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state.Gene expression changes in the nucleus accumbens of alcohol-preferring rats following chronic ethanol consumption.Implications from addiction research towards the understanding and treatment of obesity.Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts.Influence of beer, wine and spirits consumption on craving.Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients.Alteration of prolactin serum levels during alcohol withdrawal correlates with craving in female patients.Striatal activation and frontostriatal connectivity during non-drug reward anticipation in alcohol dependence.Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress.Ethanol stimulates the in vivo axonal movement of neuropeptide dense-core vesicles in Drosophila motor neurons.Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence.The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence.Relationship between substance use and body mass index in young males.Blockade of GABA(A) receptors in the paraventricular nucleus of the hypothalamus attenuates voluntary ethanol intake and activates the hypothalamic-pituitary-adrenocortical axis.Endocrine alterations during a detoxification treatment with carbamazepine in male alcoholics.Methamphetamin
P2860
Q22241964-3B573191-C8A7-451D-8A40-AB693D48851EQ24336813-81182E31-A591-4C6C-8F3E-0F43F408BB4CQ24645551-92E7F610-C61A-4FE0-87AA-3A4927AF0792Q26995739-160C9038-AE5D-4E3F-AC16-10F5E7462615Q28534147-44450AB9-C703-4426-843A-8BB35F943BE7Q30383734-82584DE4-4560-4EC4-8C02-B5860AD45762Q30537552-3152838A-BF66-4551-9B78-1AF38B99DDDBQ33996593-29D43892-C03B-4180-9714-279D3203DFDCQ34003336-A7B11197-FE15-4762-AEA7-7D7289051E4AQ34013102-60ACA325-FDBD-49A1-8FD2-6A9F40F754F3Q34190543-CB87728A-2C9F-42F5-9BB8-3FBF76638E11Q35034017-E7F3026A-8D55-4634-8291-F2F7A92DF755Q35421172-654B682C-6531-4C4E-8911-222B803195A2Q35886157-1EE0F3E4-5159-4075-B892-77DBDC619641Q36508299-F093C5B7-00B0-4C78-AC1B-F2B61089FF3AQ36526507-707A037D-1C98-460E-BD8F-89046443FB65Q36733699-EC15347F-4D6B-4DFD-BA41-CF5F9F2898CEQ36954736-D328FAD7-FC04-47E5-A302-CCD5C91FF00FQ37081753-19C687C2-92E9-4733-8FAD-86A51861BE0BQ37357479-2BFD2BE7-60D6-4AB1-BDBC-828750D7FD72Q37408597-0A4C1953-DE24-44CF-AEBD-D7136E7FD959Q37849336-6E8AB719-8679-4AA4-BE9A-7B5A7FA38081Q45933056-755327D9-1580-468B-B202-A5867CBF3826Q46726335-83F4DA37-06CC-48D2-BC5A-B637D5C4301CQ46803979-44538875-89D6-4498-A99C-D56DF7F8EDFCQ46828519-243BB78B-EB84-48D6-A907-330107DAB5DBQ47350192-2A927FAF-8A21-4681-8AF5-560CD541756EQ48218260-18C3EC85-8504-4DEE-8EF2-29E081D7F8E9Q48273071-BFDB8284-DB92-4968-BBE1-26E9F1D38773Q48487439-EABC48D4-E79D-461B-9F70-0CD734B0FBF1Q48686580-2F9D83A8-B9CA-4B36-9F96-41FEC9A7DF80Q48733951-F10BA02C-324E-4A92-AE4A-C351470FE7E2Q49044104-4A4675D5-3AF2-42D3-BA27-CC825EE8CE96Q51915605-AF8A48DA-69D0-4F15-910F-CF9E2C761BAAQ56639321-22F346DB-CC0A-4CA3-B380-4E365773C8F2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neuroendocrine pathways of addictive behaviour.
@ast
Neuroendocrine pathways of addictive behaviour.
@en
type
label
Neuroendocrine pathways of addictive behaviour.
@ast
Neuroendocrine pathways of addictive behaviour.
@en
prefLabel
Neuroendocrine pathways of addictive behaviour.
@ast
Neuroendocrine pathways of addictive behaviour.
@en
P2860
P1433
P1476
Neuroendocrine pathways of addictive behaviour.
@en
P2093
P2860
P304
P356
10.1111/J.1369-1600.2004.TB00534.X
P577
2004-09-01T00:00:00Z